Have a feature idea you'd love to see implemented? Let us know!

VANI Vivani Medical Inc

Price (delayed)

$1.33

Market cap

$78.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.44

Enterprise value

$77.48M

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in ...

Highlights
The EPS is up by 21% year-on-year and by 4.3% since the previous quarter
Vivani Medical's net income has increased by 13% YoY and by 3.1% QoQ
The equity has contracted by 30% YoY and by 23% from the previous quarter
The company's quick ratio fell by 26% QoQ and by 4.8% YoY

Key stats

What are the main financial stats of VANI
Market
Shares outstanding
59.23M
Market cap
$78.78M
Enterprise value
$77.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$23.46M
EBITDA
-$22.76M
Free cash flow
-$19.46M
Per share
EPS
-$0.44
Free cash flow per share
-$0.35
Book value per share
$0.33
Revenue per share
$0
TBVPS
$0.78
Balance sheet
Total assets
$42.9M
Total liabilities
$24.56M
Debt
$19.68M
Equity
$18.33M
Working capital
$15.13M
Liquidity
Debt to equity
1.07
Current ratio
3.41
Quick ratio
3.35
Net debt/EBITDA
0.06
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-49.2%
Return on equity
-102.4%
Return on invested capital
-63.7%
Return on capital employed
-64.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VANI stock price

How has the Vivani Medical stock price performed over time
Intraday
3.1%
1 week
-7.64%
1 month
5.56%
1 year
38.11%
YTD
30.39%
QTD
13.68%

Financial performance

How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$24.43M
Net income
-$23.46M
Gross margin
N/A
Net margin
N/A
VANI's operating income is up by 14% YoY and by 3.3% QoQ
Vivani Medical's net income has increased by 13% YoY and by 3.1% QoQ

Growth

What is Vivani Medical's growth rate over time

Valuation

What is Vivani Medical stock price valuation
P/E
N/A
P/B
4.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 21% year-on-year and by 4.3% since the previous quarter
VANI's price to book (P/B) is 40% less than its 5-year quarterly average of 6.7 but 29% more than its last 4 quarters average of 3.1
The equity has contracted by 30% YoY and by 23% from the previous quarter

Efficiency

How efficient is Vivani Medical business performance
Vivani Medical's return on invested capital has surged by 53% YoY
The return on equity has declined by 34% year-on-year and by 5% since the previous quarter
The return on assets has increased by 4.7% year-on-year but it has declined by 2.3% since the previous quarter

Dividends

What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VANI.

Financial health

How did Vivani Medical financials performed over time
The total assets is 75% more than the total liabilities
The company's quick ratio fell by 26% QoQ and by 4.8% YoY
Vivani Medical's current ratio has decreased by 25% QoQ and by 17% YoY
The debt is 7% higher than the equity
VANI's debt to equity is up by 34% year-on-year and by 27% since the previous quarter
The equity has contracted by 30% YoY and by 23% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.